GuidelineCerebellum (London, England)2020
Management of Patients with Cerebellar Ataxia During the COVID-19 Pandemic: Current Concerns and Future Implications.
Guideline in Cerebellum (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 33 citations in OpenAlex.
- Three-Week Video- and Home-Based Training Program for People with Ataxia: A Pilot Randomized Controlled Trial.Movement disorders clinical practice · 2025Trial
- The Care and Management of Children and Young People with Ataxia Telangiectasia Provided by Nurses and Allied Health Professionals: a Scoping Review.Cerebellum (London, England) · 2024Article
- The COVID-19 pandemic impact on continuity of care provision on rare brain diseases and on ataxias, dystonia and PKU. A scoping review.Orphanet journal of rare diseases · 2024Article
- Feasibility and Efficacy of Online Neuropsychological Assessment.Sensors (Basel, Switzerland) · 2023Article
- Increasing Use of Telemedicine for Neurological Disorders During the COVID-19 Pandemic: A Mini-Review.Journal of multidisciplinary healthcare · 2023Review
- Role of Drone Technology Helping in Alleviating the COVID-19 Pandemic.Micromachines · 2022Review
- COVID-19 pandemic and the international classification of functioning in multiple system atrophy: a cross-sectional, nationwide survey in Japan.Scientific reports · 2022Article
- Challenges to infection control in early communication intervention: A scoping review.The South African journal of communication disorders = Die Suid-Afrikaanse tydskrif vir Kommunikasieafwykings · 2022Article
- 2 Years into the Pandemic: What Did We Learn About the COVID-19 and Cerebellum?Cerebellum (London, England) · 2022Article
- COVID-19 and Physical Activity Behaviour in People with Neurological Diseases: A Systematic Review.Journal of developmental and physical disabilities · 2022Review
- Early Impact of the COVID-19 Pandemic on Outpatient Neurologic Care in Hawai'i.Hawai'i journal of health & social welfare · 2022Article
- Impacts of the COVID-19 Pandemic on the Mental Health and Motor Deficits in Cuban Patients with Cerebellar Ataxias.Cerebellum (London, England) · 2021Article
- Impact of SARS-CoV-2 Infection in Spinocerebellar Ataxia 12 Patients.Movement disorders : official journal of the Movement Disorder Society · 2021Article
- Anxiety and depression in spinocerebellar ataxia patients during the COVID-19 pandemic in China: A cross-sectional study.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2021Article
- Development and Validation of a Deep Learning Model to Quantify Interstitial Fibrosis and Tubular Atrophy From Kidney Ultrasonography Images.JAMA network open · 2021Article
- How COVID-19 will boost remote exercise-based treatment in Parkinson's disease: a narrative review.NPJ Parkinson's disease · 2021Review
- An intelligent framework using disruptive technologies for COVID-19 analysis.Technological forecasting and social change · 2021Article
- Friedreich ataxia in COVID-19 time: current impact and future possibilities.Cerebellum & ataxias · 2021Article
- Advantages and disadvantages of telemedicine during the COVID-19 pandemic era among physicians in Taif, Saudi Arabia.Saudi medical journal · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 11 institutions in 8 countries.
Funding
Abstract
The current worldwide severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic that causes coronavirus disease 2019 (COVID-19) has brought some medical systems to the brink of collapse. This crisis is also negatively impacting the care of patients with non-COVID-19 conditions, including those with cerebellar ataxia (CA). Older patients with CA and those with immune-mediated ataxias on immunosuppressive medication are potentially at high risk of developing serious complications of the infection, although it is also possible that immunosuppressive agents may provide a defense against cytokine storm. This has implications for even greater attention to preventing contracting the disease through physical distancing and/or isolation. The CA patient population is also at higher risk because of the neurological complexities of their underlying disorder and the comorbid medical illnesses that often accompany the genetic ataxias. As the disruption of social patterns and healthcare delivery in response to the crisis continues, interruption of rehabilitation, speech and language therapy, and face-to-face consultations threatens to have a negative impact on the course and well-being of CA patients. Mental and physical health is also potentially at greater risk because the prevailing uncertainty and anxiety may be superimposed upon cerebellum-specific neuropsychological challenges. We identify and review some of the short- and long-term consequences of this global pandemic for the community of ataxia patients and their families and for the clinical and academic neurologists/ataxiologists caring for these patients. This includes the recognition that telemedicine has emerged as a principle means of caregiver-patient contact and that neurological manifestations of COVID-19 including those specific to cerebellar neurobiology are increasingly recognized and will require close surveillance and monitoring. This COVID-19 Cerebellum Task Force consensus provides some guidance on how we may approach this uncertain time and consider preparing for the new realities we face in CA patient care once this acute crisis has passed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.